Executive Change

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________ FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported):  May 13, 2022 THE CLOROX COMPANY (Exact name of registrant as specified in its charter) ___________________   Delaware       1-07151       31-0595760 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)   1221 Broadway , Oakland , California    94612-1888 (Address of principal executive offices) (Zip code)   ( 510 ) 271-7000 (Registrant's telephone number, including area code)   Not applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: [ ] Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)   [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Name of each exchange on which registered Symbol(s) Common Stock - $1.00 par value CLX New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2). Emerging growth company            ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.            ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On May 13, 2022, the Board of Directors (the “Board”) of The Clorox Company (the “Company”) elected Julia (Charter) Denman and Stephanie Plaines to the Board, each effective as of May 16, 2022. It is expected that both Ms. Denman and Ms. Plaines will be appointed to the Audit Committee at the Board meeting in September 2022. Each of Ms. Denman and Ms. Plaines will be provided with the Company’s standard non-employee director compensation and director indemnification agreement. A press release announcing the election of Ms. Denman and Ms. Plaines is filed as Exhibit 99.1 and is incorporated herein in its entirety. Item 9.01 Financial Statements and Exhibits (d) Exhibits See the Exhibit Index below. EXHIBIT INDEX Exhibit       Description       99.1 Press Release dated May 18, 2022, of The Clorox Company   104 Cover Page Interactive Data File (embedded within the Inline XBRL document)   SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. THE CLOROX COMPANY   Date: May 18, 2022 By:          /s/ Angela Hilt Angela Hilt Senior Vice President – Chief Legal Officer